ESG

FHLBank San Francisco's major 2025 investment aims to tackle housing shortages in AZ, CA, and NV, but is it enough to turn the tide?

Endocrinologist Dr. Eiriny Eskander's Caloria app uses photo-based AI to help users on Ozempic, or with PCOS, track food beyond the scale.

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

Sharp's new EC Series dvLEDs use advanced COB technology to cut power use by 60% and installation time in half, promising a lower total cost of ownership.

A new report details a dramatic rise in ransomware and supply chain attacks, turning digital threats into life-or-death crises for the global health sector.

How booming Americas and Asia sales offset European headwinds, pushing the materials giant to 7.4% growth in a turbulent year. What's next for 2026?

BNSF Railway unveils a massive $3.6 billion capital plan for 2026, focusing on critical maintenance and strategic expansions in California and Arizona.

The acquisition strengthens the independent distributor's hold on the booming plasma therapy market, promising wider access to critical, complex medications.

A new company plans to race uncrewed spacecraft in orbit by 2028, promising a new era of sport and innovation. But can it navigate the cosmic hurdles?

As AI and algorithms reshape our world, the National Cybersecurity Alliance offers expert guidance to help you protect your personal data and digital footprint.

Avant Technologies is evaluating a therapy to protect insulin cells from immune attack, a breakthrough that could end the need for harsh drugs.

A landmark merger between XCF, DevvStream, and Southern aims to create a vertically integrated leader in sustainable aviation fuel and carbon markets.

A new report reveals a strategic shift from pandemic chaos to stable, worker-centric benefits, with financial wellness and flexibility now leading the way.

Leios Therapeutics partners with BNC Korea, securing a key investment and pathway to Asia's lucrative body contouring market for its 10XB-101 injectable.

With fresh funding, Primmune is advancing its unique TLR7 agonist, designed for efficacy without severe side effects, into a pivotal melanoma trial in Australia.

FORT Robotics' new SIL 3-certified wearable gives workers fail-safe control over machines from 200m away, boosting both safety and productivity.

Colombia's Mineros S.A. shines on the TSX30 and BVC with a 903% return, yet management argues it's deeply undervalued compared to its peers.

A worker's death at Serabi Gold's Coringa mine puts the company's ambitious growth plans and safety record under intense scrutiny in Brazil.

A hefty Q4 loss driven by a renewable diesel reversal and plant issues overshadows full-year profit, signaling a major strategic shift for 2026.

The organic kids' food brand is going public, targeting a $764M valuation. Can its rapid growth and clean-label mission overcome its significant losses?